Skip to content
Search AI Powered

Latest Stories

NPA members advised against collective action

Nick Kaye
Nick Kaye appointed as NPA's new chair
Nick Kaye appointed as NPA's new chair

With the government’s recent announcement of increased funding to the sector signalling a ‘clear step forward’, the National Pharmacy Association (NPA) has today announced that it will not be recommending collective action to its members.

Last month, the department of health announced the Community Pharmacy Contractual Framework (CPCF) with an increase in funding for 2024/25 of £106m to £2.7 billion and simultaneously a further increase to £3.1 billion for 25/26.


From April 2025, the margin allowance for community pharmacy will rise to £900 million per year.

The sector has also secured a further £215 million for Pharmacy First and other Primary Care Recovery Plan services.

“It is clear that the government has inherited an intolerable situation and the latest announcement is a step forward after 11 years of funding squeezes,” said Nick Kaye, Chair of the National Pharmacy Association.

“After much careful deliberation we have decided not to recommend our members take collective action in light of this offer, which we hope can act as a turning point after many years of neglect.”

The NPA said it wanted to work with the government to help them improve care for millions of people and bring care closer to communities through reform of primary care with community pharmacy at its heart.

However, the NPA said its members remained deeply concerned that investment remained significantly below the estimated costs of providing services for millions of patients and urged Ministers to start discussions on reform to ensure patients have sustainable services in the future.

Although the government’s funding offer was a strong positive signal to the sector and is the first real terms increase pharmacies have seen since 2014, it still leaves community pharmacy facing a gap of around £2.5 billion according to NHS England’s independent economic analysis.

The analysis also showed that half of pharmacies last year made a loss and 78 per cent were not sustainable in the short term.

In November, for the first time in its 104 year history, 99.7 per cent of the around two-thirds of pharmacies who responded to the NPA’s ballot said they would be prepared to withdraw services to patients if no substantial increase in funding was agreed.

This included the option to reduce their opening hours to contractual minimums as well as withdraw from services that they are not paid for such as free medicine deliveries.

“We are concerned that, despite much needed additional investment, pharmacies will face a substantial gap and some will still need to make tough decisions in the short term to keep their doors open,” said Kaye.

“We want to work with ministers to improve services for patients through reform that delivers stronger and more sustainable care in the community but will be watching closely to see if the additional investment will have a stabilising effect on the pharmacy network.”

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less